A 57-year old woman with a history of multiple sclerosis, treated with interferon beta-1a in the last 5 months, was referred for hyperpyrexia (>40°C) that persisted for 15 days. At admission, there was elevation of transaminases, anemia (hemoglobin 8.9 g/dL), thrombocytopenia (platelet 135,000/mm3), and hypofibrinogenemia (fibrinogen 1.26 g/L). C-reactive protein was 10.7 mg/dL, lactate dehydrogenase 1270 U/L and ferritin 2380 ng/ mL, with hepatosplenomegaly and linfoadenomegaly. Hemophagocytic lymphohistiocytosis induced by direct stimulation of macrophages by interferon (IFN) was suspected. IFN was withdrawn as only measure and onemonth later signs and symptoms disappeared, with complete normalization of laboratory examinations
Hemophagocytic lymphohistiocytosis (HLH) is a potentially fatal hyper inflammatory condition, which ...
Hemophagocytic lymphohistiocytosis (HLH) is a hyperinflammation syndrome. In adults, secondary HLH i...
Aim of this study was to investigate the activation of the IFNγ pathway in the affected liver and in...
Interferon β-1a (IFNβ1a) is considered safe in relapsing-remitting multiple sclerosis (RRMS). Drug-i...
Background: Secondary thrombotic thrombocytopenic purpura (TTP) due to interferon beta-1a intramuscu...
Interferon β-1a (IFNβ1a) is considered safe in relapsing-remitting multiple sclerosis (RRMS). Drug-i...
Hemophagocytic lymphohistiocytosis (HLH) is a rare disease entity characterized by abnormal activati...
Background: Pancytopenia is a feature of many life-threateningconditions, ranging from drug-induced ...
Background. Secondary hemophagocytic lymphohystiocytosis (sHLH) is a hyperinflammatory reaction prov...
ii Anemia is a widespread and potentially serious clinical problem. Anemia caused by inflammation ha...
INTRODUCTION Hemophagocytic Lymphohistiocytosis (HLH) is a rare, life-threatening syndrome of overwh...
Alemtuzumab is a highly effective treatment of relapsing-remitting multiple sclerosis (RRMS) with a ...
Hemophagocytic lymphohistiocytosis (HLH) is an unusual syndrome characterized by fever, splenomegaly...
Hemophagocytic lymphohistiocytosis (HLH) is an uncommon life-threatening disorder characterized by w...
Aim of this study was to investigate the activation of the IFNγ pathway in the affected liver and in...
Hemophagocytic lymphohistiocytosis (HLH) is a potentially fatal hyper inflammatory condition, which ...
Hemophagocytic lymphohistiocytosis (HLH) is a hyperinflammation syndrome. In adults, secondary HLH i...
Aim of this study was to investigate the activation of the IFNγ pathway in the affected liver and in...
Interferon β-1a (IFNβ1a) is considered safe in relapsing-remitting multiple sclerosis (RRMS). Drug-i...
Background: Secondary thrombotic thrombocytopenic purpura (TTP) due to interferon beta-1a intramuscu...
Interferon β-1a (IFNβ1a) is considered safe in relapsing-remitting multiple sclerosis (RRMS). Drug-i...
Hemophagocytic lymphohistiocytosis (HLH) is a rare disease entity characterized by abnormal activati...
Background: Pancytopenia is a feature of many life-threateningconditions, ranging from drug-induced ...
Background. Secondary hemophagocytic lymphohystiocytosis (sHLH) is a hyperinflammatory reaction prov...
ii Anemia is a widespread and potentially serious clinical problem. Anemia caused by inflammation ha...
INTRODUCTION Hemophagocytic Lymphohistiocytosis (HLH) is a rare, life-threatening syndrome of overwh...
Alemtuzumab is a highly effective treatment of relapsing-remitting multiple sclerosis (RRMS) with a ...
Hemophagocytic lymphohistiocytosis (HLH) is an unusual syndrome characterized by fever, splenomegaly...
Hemophagocytic lymphohistiocytosis (HLH) is an uncommon life-threatening disorder characterized by w...
Aim of this study was to investigate the activation of the IFNγ pathway in the affected liver and in...
Hemophagocytic lymphohistiocytosis (HLH) is a potentially fatal hyper inflammatory condition, which ...
Hemophagocytic lymphohistiocytosis (HLH) is a hyperinflammation syndrome. In adults, secondary HLH i...
Aim of this study was to investigate the activation of the IFNγ pathway in the affected liver and in...